1.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000706698, ANZGOG-0902-GOG-0274/RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
|
|
2.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000730083, CALGB-A221102, NCCTG-N10C7, A221102, NCT01573442
|
|
3.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 11113, NCI-2012-00558, NCT01613651
|
|
4.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CCCWFU 98110, U10CA081851, WFU-08-08-09, NCT01105130
|
|
5.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 7265, NCI-2011-01234, NCT01422408
|
|
6.
|
Phase: Phase II Type: Supportive care Status: Active Age: 21 to 80 Sponsor: NCI, Other Protocol IDs: OSU-10077, NCI-2012-01341, 1R21CA149675-01A1, NCT01764802
|
|
7.
|
Phase: No phase specified Type: Educational/Counseling/Training, Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000557017, MSKCC-07069, 07-069, NCT00503646
|
|
8.
|
Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: Pro00011329, CA133895-01, NCT00873665
|
|
9.
|
Phase: No phase specified Type: Natural history/Epidemiology, Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: GOG-0278, NCI-2012-01990, NCT01649089
|
|
10.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Supportive care Status: Approved-not yet active Age: 18 to 55 Sponsor: NCI, Other Protocol IDs: E1Q11, NCI-2012-02869, U10CA037403, NCT01806129
|